Bioelectrical impedance phase angle as a prognostic marker in chronic heart failure

Nutrition

Volumn 28, Issue 9, 2012, Pages 901-905

  Colín Ramírez, Eloisa ^a   Castillo Martínez, Lilia ^a   Orea Tejeda, Arturo ^a   Vázquez Durán, Marisela ^a   Rodríguez, Ana E ^a   Keirns Davis, Candace ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bioelectrical impedance; Body composition; Heart failure; Phase angle; Prognosis

Indexed keywords

ALDOSTERONE ANTAGONIST; ALDOSTERONE RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN; NITRATE; UNCLASSIFIED DRUG;

ADULT; AGE; ANTHROPOMETRY; ARTICLE; BIOCHEMISTRY; BIOELECTRICAL IMPEDANCE; BODY COMPOSITION; BODY MASS; CAUSE OF DEATH; CLASSIFICATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; ECHOCARDIOGRAPHY; FEMALE; GRIP STRENGTH; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPEDANCE; KAPLAN MEIER METHOD; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS; PHASE ANGLE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY MASS INDEX; CONFIDENCE INTERVALS; ELECTRIC IMPEDANCE; FEMALE; HAND STRENGTH; HEART FAILURE; HEMOGLOBINS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MALNUTRITION; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84864498383     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.11.033     Document Type: Article

References (31)

1. Jackson G., Gibbs C.R., Davies M.K., Lip G.Y.H. ABC of heart failure. Pathophysiology. BMJ 2000, 320:167-170.
2. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009, 119:e391-e479.
3. Lukaski H.C. Requirements for clinical use of bioelectrical impedance analysis (BIA). Ann N Y Acad Sci 1999, 873:72-76.
4. Nescolarde L., Piccoli A., Roman A., Núñez A., Morales R., Tamayo J., et al. Bioelectrical impedance vector analysis in haemodialysis patients: relation between oedema and mortality. Physiol Meas 2004, 25:1271-1280.
5. Kyle U.G., Bosaeus I., De Lorenzo A.D., Deurenberg P., Elia M., Gómez J.M., et al. Bioelectrical impedance analysis-ESPEN guidelines-part I. Review of principles and methods. Clin Nutr 2004, 23:1226-1243.
6. Barbosa-Silva M.C.G., Barros A.J.D. Bioelectrical impedance analysis in clinical practice: a new perspective on its use beyond body composition equations. Curr Opin Clin Nutr Metab Care 2005, 8:311-317.
7. Baumgartner R.N., Chumlea W.C., Roche A.F. Bioelectric impedance phase angle and body composition. Am J Clin Nutr 1988, 48:16-23.
8. Selberg O., Selberg D. Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol 2002, 86:509-516.
9. Schwenk A., Beisenherz A., Romer K., Kremer G., Salzberger B., Elia M. Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment. Am J Clin Nutr 2000, 72:496-501.
10. Faisy C., Rabbat A., Kouchakji B., Laaban J.P. Bioelectrical impedance analysis in estimating nutritional status and outcome of patients with chronic obstructive pulmonary disease and acute respiratory failure. Intensive Care Med 2000, 26:518-525.
11. Maggiore Q., Nigrelli S., Ciccarelli C., Grimaldi C., Rossi G.A., Michelassi C. Nutritional and prognostic correlates of bioimpedance indexes in hemodialysis patients. Kidney Int 1996, 50:2103-2108.
12. Ott M., Fischer H., Polat H., Helm E.B., Frenz M., Caspary W.F., et al. Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J Acquir Immune Defic Syndr 1995, 9:20-25.
13. Schwenk A., Ward L.C., Elia M., Scott G.M. Bioelectrical impedance analysis predicts outcome in patients with suspected bacteremia. Infection 1998, 26:277-282.
14. Schwenk A., Beisenherz A., Romer K., Kremer G., Salzberger B., Elia M. Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment. Am J Clin Nutr 2000, 72:496-501.
15. Gupta D., Lis C.G., Dahlk S.L., Vashi P.G., Grutsch J.F., Lammersfeld C.A. Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer. Br J Nutr 2004, 92:957-962.
16. Gupta D., Lammersfeld C.A., Burrows J.L., Dahlk S.L., Vashi P.G., Grutsch J.F., et al. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr 2004, 80:1634-1638.
17. Gupta D., Lammersfeld C.A., Vashi P.G., King J., Dahlk S.L., Grutsch J.F., et al. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer 2008, 8:249.
18. Gupta D., Lammersfeld C.A., Vashi P.G., King J., Dahlk S.L., Grutsch J.F., et al. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer. BMC Cancer 2009, 9:37.
19. Krause L., Becker M.O., Brueckner C.S., Bellinghausen C.J., Becker C., Schneider U., et al. Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis 2010, 69:1951-1957.
20. Castillo L., Colín E., Orea A., Asensio E., Bernal L.P., Rebollar V., et al. Bioelectrical impedance and strength measurements in patients with heart failure: comparison with functional class. Nutrition 2007, 23:412-418.
21. Colín-Ramírez E., Castillo-Martínez L., Orea-Tejeda A., Asensio E., Torres F., Rebollar V., et al. Body composition and echocardiographic abnormalities associated to anemia and volume overload in heart failure patients. Clin Nutr 2006, 25:746-757.
22. Silva-Tinoco R., Castillo-Martínez L., Orea-Tejeda A., Orozco-Gutiérrez J.J., Vázquez-Díaz O., Montaño-Hernández P., et al. Developing thyroid disorders is associated with poor prognosis factors in patient with stable chronic heart failure. Int J Cardiol 2011, 147:e24-e25.
23. Brenta G., Thierer J., Sutton M., Acosta A., Vainstein N., Brites F., et al. Low plasma triiodothyronine levels in heart failure are associated with a reduced anabolic state and membrane damage. Eur J Endocrinol 2011, 164:937-942.
24. Lukaski H.C., Johnson P.E., Bolonchuk W.W., Lykken G.I. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985, 41:810-817.
25. Lohman T.G., Roche A.F., Martorell R. Anthropometric standardization reference manual 1991, Human Kinetics Books, Champaign, IL. Abridged edition.
26. Norman K., Stobäus N., González M.C., Schultzke J.D., Pirlich M. Hand grip strength: outcome predictor and marker of nutritional status. Clin Nutr 2011, 30:135-142.
27. Toso S., Piccoli A., Gusella M., Menon D., Bononi A., Crepaldi G., et al. Altered tissue electric properties in lung cancer patients as detected by bioelectric impedance vector analysis. Nutrition 2000, 16:120-124.
28. Norman K., Stobäus N., Zocher D., Bosy-Westphal A., Szramek A., Scheufele R., et al. Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr 2010, 92:612-619.
29. Bosy-Westphal A., Danielzik S., Dörhöfer R., Later W., Wiese S., Müller M.J. Phase angle from bioelectrical impedance analysis: population reference values by age, sex, and body mass index. JPEN 2006, 30:309-316.
30. Orea-Tejeda A., Sánchez-González L.R., Castillo-Martínez L., Valdespino-Trejo A., Sánchez-Santillán R.N., Keirns-Davies C. Prognostic value of cardiac troponin T elevation is independent of renal function and clinical findings in heart failure patients. Cardiol J 2010, 17:42-48.
31. von Haehling S., Lainscak M., Springer J., Anker S.D. Cardiac cachexia: a systematic overview. Pharmacol Ther 2009, 121:227-252.